Zobrazeno 1 - 10
of 228
pro vyhledávání: '"G. Cance"'
Autor:
Kathleen A. Cronin, Susan Scott, Albert U. Firth, Hyuna Sung, S. Jane Henley, Recinda L. Sherman, Rebecca L. Siegel, Robert N. Anderson, Betsy A. Kohler, Vicki B. Benard, Serban Negoita, Charles Wiggins, William G. Cance, Ahmedin Jemal
Publikováno v:
Cancer. 128:4251-4284
The American Cancer Society, the Centers for Disease Control and Prevention, the National Cancer Institute, and the North American Association of Central Cancer Registries collaborate to provide annual updates on cancer occurrence and trends in the U
Autor:
Alpa V. Patel, Emily Deubler, Lauren R. Teras, Graham A. Colditz, Cari J. Lichtman, William G. Cance, Christina A. Clarke
Publikováno v:
Cancer. 128:3502-3515
This study identifies populations who may benefit most from expanded cancer screening.Two American Cancer Society prospective cohort studies, Cancer Prevention Study-II Nutrition Cohort and Cancer Prevention Study-3, were used to identify the risk fa
Autor:
Jiemin Ma, K. Robin Yabroff, Rebecca L. Siegel, William G. Cance, Howard K. Koh, Ahmedin Jemal
Publikováno v:
Journal of General Internal Medicine. 37:2923-2930
Eliminating health disparities among different segments of the US population is an overarching goal of the US Healthy People 2020 objectives.Examine changes in educational, rural-urban, and racial disparities in premature mortality during the past 10
Autor:
William G. Cance, Brian P. Eliceiri, Jisook Lee, Carl D. Morrison, Michael Yemma, Baotran Ho, Grace Huang, Vita M. Golubovskaya
PDF file - 41KB, The combination of Y15 and temozolomide decreases more significantly viability of U251 cells than each agent alone.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6a3e7076acdd6ec5210150da2698e47
https://doi.org/10.1158/1535-7163.22498914
https://doi.org/10.1158/1535-7163.22498914
Statistics for Figure 1 Excel File
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f3454c5b5facd8834d31c373f60a14
https://doi.org/10.1158/1535-7163.22508238.v1
https://doi.org/10.1158/1535-7163.22508238.v1
PathScan® RTK Signaling Antibody Array Kit Target Map (Cell Signaling) Antibodies and Other Reagents Fig. S1. Quantification of MDA-MB-453 and SkBr3 immunoblot experiments from Fig. 1; Fig. S2. Quantification of H292 and A549 immunoblot experiments
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf8a94447e89dea51701ea1d7cea4c06
https://doi.org/10.1158/1535-7163.22508244.v1
https://doi.org/10.1158/1535-7163.22508244.v1
Autor:
Lik Hang Lee, Lindy Davis, Lourdes Ylagan, Angela R Omilian, Kristopher Attwood, Canan Firat, Jinru Shia, Philip B Paty, William G Cance
Publikováno v:
J Natl Cancer Inst
Background A challenge in early-stage colorectal cancer (CRC) is identifying biomarkers that predict an increased risk for recurrence. A potential clinically adaptable biomarker is focal adhesion kinase (FAK), a tyrosine kinase that promotes invasion
Autor:
Rachel Hae-Soo, Joung, Timothy W, Mullett, Scott H, Kurtzman, Sarah, Shafir, James B, Harris, Katharine A, Yao, Karl Y, Bilimoria, William G, Cance, Heidi, Nelson, Karen, Zwicky
Publikováno v:
JAMA network open. 5(11)
Cancer screening deficits during the first year of the COVID-19 pandemic were found to persist into 2021. Cancer-related deaths over the next decade are projected to increase if these deficits are not addressed.To assess whether participation in a na
Autor:
William C. Phelps, Ginger M. Krawiec, Susanna F. Greer, Lynne W. Elmore, Elvan C. Daniels, Michael H. Melner, Charles C. Saxe, William G Cance
Publikováno v:
CA: A Cancer Journal for Clinicians. 71:107-139
We are experiencing a revolution in cancer. Advances in screening, targeted and immune therapies, big data, computational methodologies, and significant new knowledge of cancer biology are transforming the ways in which we prevent, detect, diagnose,
Autor:
Rachel H. Joung, Heidi Nelson, Timothy W. Mullett, Scott H. Kurtzman, Sarah Shafir, James B. Harris, Katharine A. Yao, Brian C. Brajcich, Karl Y. Bilimoria, William G. Cance
Publikováno v:
Cancer
Cancer-related deaths over the next decade are expected to increase due to cancer screening deficits associated with the coronavirus disease 2019 (COVID-19) pandemic. Although national deficits have been quantified, a structured response to identifyi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da119dab332077b12352f5d5d932a0c8
https://europepmc.org/articles/PMC9086125/
https://europepmc.org/articles/PMC9086125/